Bristol Myers Squibb Co. said Sunday it will buy Mirati Therapeutics Inc. in a deal valued at up to $5.8…
Browsing: Mirati
Drew Angerer/Getty Images News Bristol-Myers Squibb (NYSE:BMY) agreed to purchase Mirati Therapeutics (NASDAQ:MRTX) for about $4.8 billion. Bristol-Myers (BMY) agreed…
Mohammed Haneefa Nizamudeen As the FDA continues to mull the fate of Amgen’s lung cancer drug Lumakras, Sanofi is reportedly…
jittawit.21 Citi has upgraded its rating for Mirati Therapeutics (NASDAQ:MRTX) to buy, citing the company’s decision to have its founder…
Mirati up 4% as Krazati granted Breakthough Therapy designation for colorectal cancer Source link
By Investing.com Staff After surging nearly 16% Tuesday on fresh takeover rumors, Mirati Therapeutics (NASDAQ:) is adding another 5% Wednesday…
Nastassia Samal Mirati Therapeutics (NASDAQ:MRTX) rose 4.5% after jumping 15% on Tuesday on a report that the cancer drug company…